Market Fit Target health systems, health plans, and value-based care organizations seeking earlier detection of cognitive decline to reduce hospitalizations and optimize reimbursement under CMS models. Neurotrack’s EMR integrations and home/self-administered screenings are aligned with procurement for digital cognitive health tools in integrated care networks.

Expansion Potential Leverage recent partnerships and growing revenue trajectory to scale sales with multi-site health systems and regional health plans. Highlight success with Desert Oasis Healthcare and Midi Health collaborations to illustrate cross-specialty applicability (menopause brain fog, general cognitive screening) and expand into additional primary care, geriatrics, and women's health segments.

Technology Edge Emphasize the fast, digital, clinic-ready and at-home screening capability that fits into routine visits, reducing clinician time and increasing screening rates. Promote seamless Epic integration and cloud-based tools to address interoperability concerns of large health networks and to accelerate vendor onboarding.

Financial Upside Position value proposition around cost containment and reimbursement optimization under CMS risk-adjustment models, with evidence of earlier diagnosis reducing avoidable utilization. Use revenue milestones (recent $4.2M in 2025) and overall funding to bolster ROI arguments for CIOs and CFOs evaluating cognitive care tech.

Growth Signals Capitalize on funding history and leadership hires such as the Chief Growth Officer to frame Neurotrack as a scalable growth partner. Target mid-market to enterprise customers with digital screening needs, and prepare case studies from past partnerships to shorten sales cycles and accelerate pilots in new regions.